Nexalin names Abbott, Medtronic veteran Robert DiTota senior strategic advisor for global commercialization
Bitget2026/09/29 13:05- Nexalin Technology appointed neuromodulation executive Robert DiTota as senior strategic advisor for global commercialization, effective Sept. 15, 2026.
- DiTota will advise management on commercial strategy, international distribution, market development, go-to-market planning, commercial infrastructure, organizational buildout.
- He spent more than 20 years in neuromodulation at Abbott, most recently divisional VP of sales for North America commercial neuromodulation.
- DiTota previously worked at Medtronic for nine years, supporting deep brain stimulation in New York and the Activa platform launch.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pi Network News: PI Price Jumps 4% as Team Announces Three-Day Developer Summit
These Alts Bleed the Most as Bitcoin (BTC) Settles Below $82K: Weekend Watch
New York Fed warns: Service sector input and sales prices surge, significant price pressure
A survey by the New York Federal Reserve shows that service sector input costs and prices in October rose sharply, while the business activity index fell to its lowest level since March. Businesses have turned pessimistic about the outlook, with increasing inflation and interest rate pressures.
Crypto prices
More
